Compare Monster Beverage Corp (MNST) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monster Beverage Corp vs NeoGenomics Inc. Common Stock — how do they compare? Monster Beverage Corp trades at $44.78 (market cap $86.63B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: Monster Beverage Corp is far larger — about 39.9× NeoGenomics Inc. Common Stock's market cap, and Monster Beverage Corp is more actively traded (11,197,663 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold Monster Beverage Corp for 72 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MNST | NEO | |
|---|---|---|
Market Cap | $86.63B | $2.17B |
Volume | 11,197,663 | 1,615,943 |
Sector | Consumer Staples | Health |
52-Week High | $49.97 | $19.91 |
52-Week Low | $33.16 | $7.19 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $84.92B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.31, down 1.03% today, with a bullish technical signal supported by moving averages. The company demonstrates strong fundamentals with 2025 revenue of $8.29B, net income of $1.91B (23.08% margin), and consistent earnings beats in recent quarters. Recent news highlights international expansion success and a debt-free balance sheet as key strengths, while a 1:2 stock split occurred in August 2026.
MNST presents a compelling growth story with robust profitability and international momentum, though elevated valuation multiples (P/E 40.1) warrant caution. Analyst consensus remains positive with a $98.22 price target (52.27% buy ratings), but regulatory challenges in key markets like India and competitive pressures represent ongoing risks for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
